Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01164566 · ClinicalTrials.gov registry record · NA

Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radiation Therapy and/or Chemotherapy

A NA study, sponsored by Wake Forest University Health Sciences.

Terminated
Registry status
NA
Development phase
6
Enrollment target

NCT01164566: Clinical Trial NA study, sponsored by Wake Forest University Health Sciences.

NCT01164566 is a NA study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01164566, a NA study, was terminated before completion, sponsored by Wake Forest University Health Sciences.

TERMINATED
Registry status
NA
Development phase
6 participants
Enrollment target

Study Summary

Brief Summary: RATIONALE: Comparing results of diagnostic procedures, such as esophagoscopy, done before and after radiation therapy and/or chemotherapy may help doctors predict a patient's response to treatment and help plan the best treatment. PURPOSE: This clinical trial is studying esophagoscopy in evaluating treatment in patients with stage I-IV head and neck cancer who are undergoing radiation therapy and/or chemotherapy.

Primary Outcome

Abnormal endoscopic esophageal examination, as defined by presence of: stricture, web, ring, erosive esophagitis, fungal esophagitis, viral esophagitis, Barrett's metaplasia, neoplasm, or other.

Interventions

  • OTHER questionnaire administration
  • PROCEDURE endoscopic procedure

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2010-12
Est. Completion 2012-03
Phase NA
Wake Forest University Health Sciences

1,140 total trials

Why NCT01164566 stopped before completion

NCT01164566 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 2 interventions - of which questionnaire administration is the first listed.

NCT01164566 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01164566 about?

NCT01164566 is a clinical study titled "Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radiation Therapy and/or Chemotherapy". Brief Summary: RATIONALE: Comparing results of diagnostic procedures, such as esophagoscopy, done before and after radiation therapy and/or chemotherapy may help doctors predict a patient's response to treatment and help plan the best treatment. PURPOSE: This clinical trial is studying esophagosco...

What is the current status of trial NCT01164566?

This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2010-12. Estimated completion is 2012-03.

What interventions are being tested in trial NCT01164566?

The interventions under investigation include: questionnaire administration (OTHER), endoscopic procedure (PROCEDURE).

Who is sponsoring clinical trial NCT01164566?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01164566's enrollment target sits among peer trials

6 1983rd of 2000 higher than 13 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01164566, the US trial registry maintained by the National Library of Medicine. NCT01164566 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.